Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown & Brown
BRO
|
+$500M |
| 2 |
Arista Networks
ANET
|
+$316M |
| 3 |
Union Pacific
UNP
|
+$271M |
| 4 |
Eli Lilly
LLY
|
+$271M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$495M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$388M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$385M |
| 4 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$369M |
| 5 |
Mastercard
MA
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.78% |
| 2 | Consumer Discretionary | 9.99% |
| 3 | Financials | 9.73% |
| 4 | Industrials | 7.81% |
| 5 | Healthcare | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KREF
1301
KKR Real Estate Finance Trust
KREF
$491M
| $4.7M | 0.01% |
536,084
+421,657
| +368% | +$3.88M |
|
1302
Diodes
DIOD
$4.25B
| $4.7M | 0.01% |
88,863
+21,928
| +33% | +$964K |
|
1303
Core Scientific
CORZ
$5.79B
| $4.67M | 0.01% |
+273,290
| New | +$2.73M |
|
1304
Dyne Therapeutics
DYN
$4.91B
| $4.65M | 0.01% |
+488,498
| New | +$5.38M |
|
1305
LiveRamp
RAMP
$2.29B
| $4.62M | 0.01% |
139,881
+123,683
| +764% | +$3.59M |
|
1306
Veracyte
VCYT
$3.52B
| $4.6M | 0.01% |
+170,248
| New | +$4.93M |
|
1307
CALL
Palo Alto Networks
PANW
$277B
| $4.58M | 0.01% |
22,400
-700
| -3% | -$130K |
|
1308
CALL
Nutrien
NTR
$34.7B
| $4.58M | 0.01% |
78,600
+13,900
| +21% | +$785K |
|
1309
PUT
UiPath
PATH
$8.62B
| $4.57M | 0.01% |
356,800
+281,800
| +376% | +$3.38M |
|
1310
Perdoceo Education
PRDO
$2.09B
| $4.56M | 0.01% |
139,645
-111,732
| -44% | -$3.31M |
|
1311
Loews
L
$22.7B
| $4.56M | 0.01% |
49,797
-49,296
| -50% | -$4.33M |
|
|
OKLO
1312
PUT
Oklo
OKLO
$8.23B
| $4.56M | 0.01% |
81,500
+56,500
| +226% | +$2.18M |
|
1313
PUT
DexCom
DXCM
$33.7B
| $4.54M | 0.01% |
52,000
-2,300
| -4% | -$180K |
|
1314
Franklin Electric
FELE
$4.51B
| $4.52M | 0.01% |
50,313
-22,372
| -31% | -$1.96M |
|
|
KRMN
1315
Karman Holdings
KRMN
$6.54B
| $4.5M | 0.01% |
89,297
-630,222
| -88% | -$25.4M |
|
|
VTLE
1316
DELISTED
Vital Energy
VTLE
| $4.49M | 0.01% |
279,270
-188,200
| -40% | -$3.08M |
|
1317
CALL
Moderna
MRNA
$63.6B
| $4.48M | 0.01% |
162,300
+145,600
| +872% | +$3.83M |
|
1318
Zillow
Z
$8.11B
| $4.47M | 0.01% |
+63,877
| New | +$4.3M |
|
1319
CALL
Riot Platforms
RIOT
$7.95B
| $4.47M | 0.01% |
395,400
+122,700
| +45% | +$1.04M |
|
1320
Remitly
RELY
$5.54B
| $4.47M | 0.01% |
238,032
+174,491
| +275% | +$3.63M |
|
1321
Century Aluminum
CENX
$4.38B
| $4.45M | 0.01% |
247,106
+68,168
| +38% | +$1.16M |
|
1322
JFrog
FROG
$11B
| $4.45M | 0.01% |
+101,391
| New | +$3.85M |
|
1323
PUT
Capital One
COF
$133B
| $4.45M | 0.01% |
20,900
+18,500
| +771% | +$3.45M |
|
1324
John Wiley & Sons Class A
WLY
$2.74B
| $4.44M | 0.01% |
99,486
+81,155
| +443% | +$3.42M |
|
1325
PUT
Match Group
MTCH
$9.66B
| $4.43M | 0.01% |
143,400
+118,500
| +476% | +$3.54M |
|
Similar funds
Dmitry Balyasny's Q2 2025 Portfolio in Review
As of Q2 2025, Dmitry Balyasny held 3,510 positions worth $66.4B, up 9.8% from $60.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Dmitry Balyasny's Q2 2025 filing shows 779 new, 864 increased, 1,015 reduced and 774 closed positions. Its largest new stake was Arista Networks: 3,646,977 shares worth $373M. The largest sale was iShares Core S&P 500 ETF, an estimated $495M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Financials.
- Dmitry Balyasny's largest Q2 2025 buy was Arista Networks: 3,646,977 shares worth $373M.
- Dmitry Balyasny added most to Brown & Brown in Q2 2025, an estimated $500M increase.
- Dmitry Balyasny's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $495M.
- Dmitry Balyasny fully exited Vanguard Morningstar Total Stock Market ETF in Q2 2025, selling an estimated $369M.
- Dmitry Balyasny's ten largest holdings make up 13% of its $66.4B portfolio in Q2 2025.
- Dmitry Balyasny opened 779 new positions and closed 774 in Q2 2025.
- Dmitry Balyasny's portfolio value rose 9.8% quarter-over-quarter to $66.4B.
Based on Balyasny Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.